Aclaris Therapeutics

IPO

Home | Aclaris Therapeutics Inc.

Public · St. Louis, United States · Founded 2012 · $122.0M raised

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$122.0M
Last Round
$80.0M Private EquityJan 2020
Rounds
3
Type
Public

About

Aclaris Therapeutics focuses on drug discovery and development and kinase inhibition to create novel small and large molecule drugs for people impacted by underserved immuno-inflammatory conditions. Scientists use the proprietary KINect technology platform to design kinase inhibitors that target enzymes involved in chronic inflammation, autoimmune disease, and the regulation of cancer growth. The company also develops biologic candidates such as monoclonal and bispecific antibodies that target validated immune-inflammatory pathways, and operates Confluence Discovery Technologies as a drug-discovery contract research organization for pharma and biotech partners.

Summary

Aclaris Therapeutics is a Biotech company based in St. Louis, United States, founded in 2012. It has raised $122.0M in total across 3 rounds, most recently a $80.0M Private Equity round in Jan 2020. Investors include Vivo Capital, Fidelity Biosciences and Sofinnova Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityJan 2020
$80.0M

Sign up to see all 4 rounds

Series A through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aclaris Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/aclaris-therapeutics"><img src="https://indexed.vc/api/badge/company/aclaris-therapeutics" alt="Aclaris Therapeutics on Indexed.vc" width="260" height="76" /></a>